Literature DB >> 22821969

Virulence or niche factors: what's in a name?

Colin Hill1.   

Abstract

The increasing interest in the human microbiota raises some interesting questions about the terminology we use to describe some of the structures and strategies employed by commensal and pathogenic microbes to compete in these complex biological ecosystems. For example, all microbes arriving in the alimentary tract face the task of surviving passage through the stomach, coping with bile, interacting with the immune system, competing with the established microbiota, and obtaining sufficient nutrients to gain a foothold in this hostile environment. It is not surprising then that many gastrointestinal microbes (both pathogens and commensals) use similar strategies to overcome the challenges associated with this particular biological niche. Given that many of these structures and strategies were discovered and characterized in pathogens and because they often play important roles in establishing and maintaining an infection, they have often been characterized as virulence factors. It would be misleading to describe the same strategies and structures found in harmless commensals as "virulence factors," since they represent a sine qua non for life in the gastrointestinal tract. It may be time to reconsider and refer to them as "niche factors," both in terms of providing scientific accuracy but also in light of the growing interest in using gut microbes as probiotics, where the distinction between virulence factors and niche factors is likely to be very important from a regulatory perspective.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821969      PMCID: PMC3486107          DOI: 10.1128/JB.00980-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  8 in total

Review 1.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

2.  Transcriptional activation of the tad type IVb pilus operon by PypB in Yersinia enterocolitica.

Authors:  Jennifer Schilling; Karin Wagner; Stephanie Seekircher; Lilo Greune; Verena Humberg; M Alexander Schmidt; Gerhard Heusipp
Journal:  J Bacteriol       Date:  2010-05-14       Impact factor: 3.490

3.  Endocarditis and biofilm-associated pili of Enterococcus faecalis.

Authors:  Sreedhar R Nallapareddy; Kavindra V Singh; Jouko Sillanpää; Danielle A Garsin; Magnus Höök; Stanley L Erlandsen; Barbara E Murray
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

4.  Contribution of three bile-associated loci, bsh, pva, and btlB, to gastrointestinal persistence and bile tolerance of Listeria monocytogenes.

Authors:  Máire Begley; Roy D Sleator; Cormac G M Gahan; Colin Hill
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  A PrfA-regulated bile exclusion system (BilE) is a novel virulence factor in Listeria monocytogenes.

Authors:  Roy D Sleator; Henrike H Wemekamp-Kamphuis; Cormac G M Gahan; Tjakko Abee; Colin Hill
Journal:  Mol Microbiol       Date:  2005-02       Impact factor: 3.501

6.  Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor.

Authors:  Mary O'Connell Motherway; Aldert Zomer; Sinead C Leahy; Justus Reunanen; Francesca Bottacini; Marcus J Claesson; Frances O'Brien; Kiera Flynn; Patrick G Casey; Jose Antonio Moreno Munoz; Breda Kearney; Aileen M Houston; Caitlin O'Mahony; Des G Higgins; Fergus Shanahan; Airi Palva; Willem M de Vos; Gerald F Fitzgerald; Marco Ventura; Paul W O'Toole; Douwe van Sinderen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

7.  Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis.

Authors:  Olivier Dussurget; Didier Cabanes; Pierre Dehoux; Marc Lecuit; Carmen Buchrieser; Philippe Glaser; Pascale Cossart
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

8.  Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein.

Authors:  Matti Kankainen; Lars Paulin; Soile Tynkkynen; Ingemar von Ossowski; Justus Reunanen; Pasi Partanen; Reetta Satokari; Satu Vesterlund; Antoni P A Hendrickx; Sarah Lebeer; Sigrid C J De Keersmaecker; Jos Vanderleyden; Tuula Hämäläinen; Suvi Laukkanen; Noora Salovuori; Jarmo Ritari; Edward Alatalo; Riitta Korpela; Tiina Mattila-Sandholm; Anna Lassig; Katja Hatakka; Katri T Kinnunen; Heli Karjalainen; Maija Saxelin; Kati Laakso; Anu Surakka; Airi Palva; Tuomas Salusjärvi; Petri Auvinen; Willem M de Vos
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

  8 in total
  28 in total

1.  Antibiotic resistance, efflux pump genes and virulence determinants in Enterococcus spp. from surface water systems.

Authors:  L G Molale; Cornelius Carlos Bezuidenhout
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-11       Impact factor: 4.223

2.  Safety of the surrogate microorganism Enterococcus faecium NRRL B-2354 for use in thermal process validation.

Authors:  Lauren M Kopit; Eun Bae Kim; Roland J Siezen; Linda J Harris; Maria L Marco
Journal:  Appl Environ Microbiol       Date:  2014-01-10       Impact factor: 4.792

3.  Surface proteome analysis of a natural isolate of Lactococcus lactis reveals the presence of pili able to bind human intestinal epithelial cells.

Authors:  Mickael Meyrand; Alain Guillot; Mélodie Goin; Sylviane Furlan; Julija Armalyte; Saulius Kulakauskas; Naima G Cortes-Perez; Ginette Thomas; Sophie Chat; Christine Péchoux; Vincent Dupres; Pascal Hols; Yves F Dufrêne; Germain Trugnan; Marie-Pierre Chapot-Chartier
Journal:  Mol Cell Proteomics       Date:  2013-09-03       Impact factor: 5.911

4.  Safety Evaluation of Lactobacillus delbrueckii subsp. lactis CIDCA 133: a Health-Promoting Bacteria.

Authors:  Luís Cláudio Lima de Jesus; Thiago de Jesus Sousa; Flávia Figueira Aburjaile; Vasco Azevedo; Nina Dias Coelho-Rocha; Rodrigo Profeta; Fernanda Alvarenga Lima Barroso; Mariana Martins Drumond; Pamela Mancha-Agresti; Ênio Ferreira; Bertram Brenig
Journal:  Probiotics Antimicrob Proteins       Date:  2021-08-17       Impact factor: 5.265

5.  Functional screening of a metagenomic library reveals operons responsible for enhanced intestinal colonization by gut commensal microbes.

Authors:  Mi Young Yoon; Kang-Mu Lee; Yujin Yoon; Junhyeok Go; Yongjin Park; Yong-Joon Cho; Gerald W Tannock; Sang Sun Yoon
Journal:  Appl Environ Microbiol       Date:  2013-04-12       Impact factor: 4.792

Review 6.  Homeostasis and catabolism of choline and glycine betaine: lessons from Pseudomonas aeruginosa.

Authors:  Matthew J Wargo
Journal:  Appl Environ Microbiol       Date:  2013-01-25       Impact factor: 4.792

7.  Nonclinical and clinical Enterococcus faecium strains, but not Enterococcus faecalis strains, have distinct structural and functional genomic features.

Authors:  Eun Bae Kim; Maria L Marco
Journal:  Appl Environ Microbiol       Date:  2013-10-18       Impact factor: 4.792

8.  Gene loss through pseudogenization contributes to the ecological diversification of a generalist Roseobacter lineage.

Authors:  Xiao Chu; Siyao Li; Sishuo Wang; Danli Luo; Haiwei Luo
Journal:  ISME J       Date:  2020-09-30       Impact factor: 10.302

9.  Comparative genome analysis of Streptococcus infantarius subsp. infantarius CJ18, an African fermented camel milk isolate with adaptations to dairy environment.

Authors:  Christoph Jans; Rainer Follador; Mira Hochstrasser; Christophe Lacroix; Leo Meile; Marc J A Stevens
Journal:  BMC Genomics       Date:  2013-03-22       Impact factor: 3.969

10.  Virulence Factor Genes Detected in the Complete Genome Sequence of Corynebacterium uterequi DSM 45634, Isolated from the Uterus of a Maiden Mare.

Authors:  Christian Rückert; Martin Kriete; Sebastian Jaenicke; Anika Winkler; Andreas Tauch
Journal:  Genome Announc       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.